OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership
OptimizeRx / Equals 5 partnership extends clinically-relevant messaging to social media with a combination of RWD, AI, and NPI targeting
OptimizeRx Completes Platform Integration of TelaRep(TM) One-Click Prescriber Connectivity Solution
Originally launched in April 2020, TelaRep has been adopted by the majority of OptimizeRx's EHR network partners and is now in use by over 200,000 HCPs.
OptimizeRx to Participate in Upcoming June Conferences
OPRX will participate in three bank-sponsored investor conferences in June 2022
OptimizeRx Authorizes $20 Million Share Repurchase Program
The OptimizeRx Board of Directors has unanimously authorized a share repurchase program.
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
Rousselle is a healthcare data science leader leveraging RWD, artificial intelligence (AI) and machine learning (ML) to garner actionable insights
It’s Time to Acknowledge Access as a Prescribing Barrier
A recent survey found that on average doctors would prescribe a different therapy for 33% of their patients if medication access was not a factor.
